510(k) · Cleared
ClearedIridex 810 Laser
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Iridex Corporation · HQF Laser, Ophthalmic
Cleared on Oct 21, 2020 as substantially equivalent to K020374 (Iridex Corp, 2002) after a 30-day review. Its family tree reaches back 3 generations to 1989. 1 later device descends from it.
- Decided
- Oct 21, 2020
- Review
- 30 days
- Class
- Class II
- Product code
- HQF
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K894841 (1989). 9 ancestors in all, the oldest K890086 (1989). 1 later device descends from it, 1 citing it directly.
- Root · 3 generations backK894841 Iris Oculight (TM) SLIriderm Div. · 1989
- 2 generations backK960971 Oculight GLIriderm Div. · 1996
- 1 generation backK020374 Oculight SL/SLXIridex Corp · 2002
- This deviceK202760 Iridex 810 LaserIridex Corporation · 2020
- Descendant · cites it directly · 0 of its ownK213592 Iridex 810 LaserIridex Corporation · 2022
Most influential descendants
Showing 1 of 1 · See all- K213592Iridex 810 LaserIridex Corporation · 2022 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K894841 | Iris Oculight (TM) SL | Iriderm Div. | 1989 | — |
| −2 | K960971 | Oculight GL | Iriderm Div. | 1996 | — |
| −1 | K020374 | Oculight SL/SLX | Iridex Corp | 2002 | — |
| 0 (this device) | K202760 | Iridex 810 Laser | Iridex Corporation | 2020 | — |
| +1 | K213592 | Iridex 810 Laser | Iridex Corporation | 2022 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1989 | 1 | 0 |
| 1991 | 3 | 0 |
| 1994 | 1 | 0 |
| 2002 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2022 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in HQF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new HQF device
- #1 K251772 Navilas Laser System 577sl (156691)score 13.6 · 12 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K020374 | Oculight SL/SLXSummary page 5…90, 21 CFR 886.4810 Device Class: II Predicate Device Company: Iridex Corporation Device: OcuLight SL/SLx, Model # 13030 (K020374) Page 1 of 8… | 2002 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K213592 | Iridex 810 Laser | 2022 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 31 years and passes through 3 companies; a new generation was cleared every 6.9 years on median.
- None of the 9 ancestors has a recall.
- Of its descendants, K213592 (Iridex Corporation, 2022) has gone furthest, with 0 descendants of its own.
- 8 other devices also cite its predicate K020374.
How does its category compare?
All HQF devicesHQF Laser, Ophthalmic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.
FDA decisions per year · HQF
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · HQF
264in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · HQF
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · HQF
106in 2025
MAUDE reports naming product code HQF, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 198 | 2 | 60 |
| 2008 | 3 | 28 | 1 | 34 |
| 2009 | 7 | 115 | 2 | 33 |
| 2010 | 2 | — | 3 | 43 |
| 2011 | 4 | 128 | 5 | 26 |
| 2012 | 5 | 179 | 1 | 41 |
| 2013 | 6 | 225 | 2 | 39 |
| 2014 | 3 | 215 | 4 | 58 |
| 2015 | 4 | 295 | 0 | 80 |
| 2016 | 3 | 271 | 0 | 108 |
| 2017 | 3 | 189 | 0 | 77 |
| 2018 | 1 | — | 0 | 82 |
| 2019 | 4 | 107 | 0 | 66 |
| 2020 | 4 | 53 | 0 | 72 |
| 2021 | 1 | — | 0 | 100 |
| 2022 | 7 | 86 | 0 | 111 |
| 2023 | 5 | 155 | 0 | 92 |
| 2024 | 3 | 167 | 0 | 75 |
| 2025 | 3 | 264 | 1 | 106 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The Iridex 810 Laser is indicated for retinal photocoagulation, laser trabeculoplasty, transscleral cyclophotocoagulation, transscleral retinal photocoagulation, and other diode laser treatments. The following are examples of applications for the Iridex 810 Laser. CONDITION TREATMENT Diabetic Retinopathy Panretinal Photocoagulation (PRP); • Nonproliferative Retinopathy Focal and Grid Laser Treatments • Macular Edema • Proliferative Retinopathy Glaucoma…
Read the full statement (147 words)
The Iridex 810 Laser is indicated for retinal photocoagulation, laser trabeculoplasty, transscleral cyclophotocoagulation, transscleral retinal photocoagulation, and other diode laser treatments. The following are examples of applications for the Iridex 810 Laser.
CONDITION TREATMENT
Diabetic Retinopathy Panretinal Photocoagulation (PRP);
• Nonproliferative Retinopathy Focal and Grid Laser Treatments
• Macular Edema
• Proliferative Retinopathy
Glaucoma Laser Trabeculoplasty; Iridotomy;
• Primary Open Angle Transscleral Cyclophotocoagulation (TSCPC)
• Closed Angle
• Refractory Glaucoma (recalcitrant/uncontrolled)
Retinal Tears, Detachments, and Holes Transscleral Retinal Photocoagulation (TSRPC);
Focal and Grid Laser Treatments
Lattice Degeneration PRP; Focal and Grid Laser Treatments
Age-Related Macular Degeneration (AMD) Focal and Grid Laser Treatments
Intra-Ocular Tumors Focal and Grid Laser Treatments
• Choroidal Hemangioma
• Choroidal Melanoma
• Retinoblastoma
Retinopathy of Prematurity PRP; TSRPC; Focal and Grid Laser Treatments
Sub-Retinal (choroidal) Neovascularization Focal and Grid Laser Treatments
Central and Branch Retinal Vein Occlusion PRP; Focal and Grid Laser Treatments
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K202760 · printed Nov 6, 2026
Cite this page
510(k) Report. “K202760: Iridex 810 Laser.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K202760
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026